Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-01T09:08:22.074Z Has data issue: false hasContentIssue false

4 - New product development (NPD)

Published online by Cambridge University Press:  05 September 2012

Shreefal S. Mehta
Shreefal S. Mehta
Affiliation:
Cytopia
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Commercializing Successful Biomedical Technologies
Basic Principles for the Development of Drugs, Diagnostics and Devices
 , pp. 104 - 171
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pollack, A. High court rethinks what can be patented, The New York Times, Monday, March 20, 2006.
Lipinski, C A, Lombardo, F, Dominy, B W, and Feeney, P.Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews, 23, 3–25, 1997.CrossRefGoogle Scholar
Bossuyt, P M, Reitsma, J B, Bruns, D E, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration, Clinical Chemistry, 49, 7–18, 2003.CrossRefGoogle ScholarPubMed
Block, Z. and MacMillan, I. C.Corporate Venturing: Creating New Businesses within the Firm, Harvard Business School Press, 1993.Google Scholar
Christensen, C.The Innovator's Dilemma: The Revolutionary Book that Will Change the Way You Do Business, Harvard Business School Press, Reprint 2003.Google Scholar
Cooper, R. G.The new product process: a decision guide for managers. Journal of Marketing Management, 3, (3) 238–255, 1988.CrossRefGoogle Scholar
DiMasi, J. A., Hansen, R. W., and Grabowski, H. G.The price of innovation: new estimates of drug development costs, Journal of Health Economics, 22, 151–185, 2003.CrossRefGoogle Scholar
Fries, R. (ed.). Handbook of Medical Device Design, Marcel Dekker Press, 2001.Google Scholar
Gad, S. C. (ed.). Drug Discovery Handbook, Wiley-Interscience, 2005.CrossRefGoogle Scholar
Galbraith, J. R., Matrix organization designs – how to combine functional and project forms, Business Horizons, 17, 1, 29–40, 1971.CrossRefGoogle Scholar
Gray, C. F. and Larson, E.Project Management: The Managerial Process, McGraw-Hill/Irwin, 3rd edn., 2006.Google Scholar
Justiniano, J. and Gopalaswamy, V.Six Sigma for Medical Device Design, CRC Press, 2004.Google Scholar
Krogsgaard-Larsen, P, Liljefors, T, and Madsen, U (eds.). Textbook of Drug Design and Discovery, CRC Press, 3rd edn., 2002.Google Scholar
Larson, E. W. and Gobeli, D. H.Organizing for product development projects, Journal of Product Innovation Management, 5, 180–190, 1988.CrossRefGoogle Scholar
Leifer, R., McDermott, C. M., O'Connor, G. C., et al. Radical Innovation: How Mature Companies can Outsmart Upstarts, Harvard Business School Press, 2000.Google Scholar
Lynn, G. S, Morone, J. G., and Paulson, A. S.Marketing and discontinuous innovation: the probe and learn process, California Management Review, 38(3), 8–37, 1996.CrossRefGoogle Scholar
Metzler, R.Biomedical and Clinical Instrumentation: Fast Tracking from Concept through Production in a Regulated Environment. Interpharm Press, 1994.Google Scholar
Pisano, G. P.The Development Factory: Unlocking the Potential of Process Innovation, Harvard Business School Press, 1996.Google Scholar
Prentis, R. A., Lis, Y., and Walker, S. R.Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985), British Journal of Clinical Pharmacology, 25, 387–396, 1988.CrossRefGoogle Scholar
Project Management Institute, A Guide to the Project Management Body of Knowledge (PMBOK®), Project Management Institute, 3rd edn., 2004.
Sapienza, A. M.Creating Technology Strategies: How to Build Competitive Biomedical R&D, Wiley-Liss, 1997.Google Scholar
Whitmore, E.Development of FDA-Regulated Medical Products: Prescription Drugs, Biologics, and Medical Devices, ASQ Quality Press, 2nd edn., 2003.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×